Equities

OptimizeRx Corp

OPRX:NAQ

OptimizeRx Corp

Actions
Health CareHealth Care Providers
  • Price (USD)7.88
  • Today's Change0.02 / 0.25%
  • Shares traded277.80k
  • 1 Year change+5.07%
  • Beta1.2729
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.

  • Revenue in USD (TTM)83.20m
  • Net income in USD-17.91m
  • Incorporated2008
  • Employees116.00
  • Location
    OptimizeRx Corp260 CHARLES STREET, SUITE 302WALTHAM 02453United StatesUSA
  • Phone+1 (248) 651-6558
  • Fax+1 (248) 453-5529
  • Websitehttps://www.optimizerx.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
OPRX:NAQ since
announced
Transaction
value
Healthy Offers IncDeal completed12 Oct 202312 Oct 2023Deal completed10.21%95.00m
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
FingerMotion Inc32.00m-4.15m115.44m64.00--10.54--3.61-0.0789-0.07890.60990.20771.56--3.46499,946.60-20.55-44.86-33.60-79.0512.139.79-13.14-19.96----0.00--5.1089.2850.16---49.62--
Marti Technologies Inc20.03m-33.81m117.17m553.00------5.85-0.6686-0.66860.404-0.5733------36,219.80---------9.21---168.82--1.32-9.612.00---19.84---137.36------
Gaia Inc84.71m-6.18m120.62m109.00--1.4610.121.42-0.2684-0.26843.733.510.6056--20.11777,165.10-4.20-3.72-5.79-4.6685.1386.54-6.93-6.19---6.670.0578---1.9713.88-64.32---22.50--
Rego Payment Architectures Inc0.00-12.62m137.51m4.00---------0.093-0.0930.00-0.23940.00----0.00-128.46-500.28-----------160,161.30---8.85-----100.00---6.95--40.22--
Mondee Holdings Inc232.97m-92.40m139.87m1.23k------0.6004-1.17-1.172.960.05060.628--1.98190,026.10-21.10---36.84-------33.59-----0.66290.9763--40.03--19.80------
OPTIMIZERx Corp83.20m-17.91m144.01m116.00--1.19--1.73-1.00-1.004.706.610.5656--3.89717,262.30-12.18-6.84-13.09-7.5261.9659.67-21.53-12.91---3.990.2273--14.5327.52-53.57--57.12--
eGain Corp92.80m7.78m147.12m539.0020.942.5718.011.590.24640.24642.952.010.7195--2.93172,176.306.033.8211.827.9770.2772.388.384.98----0.000.00-5.316.66268.9013.29-13.03--
Cango Inc - ADR83.96m3.28m148.44m632.0072.160.3081--1.770.02190.02190.75475.130.1164--1.79132,845.900.45475.850.57418.1120.6132.463.9123.62----0.0004108.59-14.069.2996.59---34.13--
Arax Holdings Corp.984.05k-17.71m149.06m----20.62697.73151.47-0.1287-0.12870.00820.05580.0725--1.63---130.56---134.99--53.72---1,800.10----564.780.00-------12,378.02------
WM Technology Inc179.43m-6.69m150.36m440.00--6.1519.410.838-0.0717-0.07171.880.16051.01--16.33407,786.40-5.94---19.42--94.24---5.901.20----0.00---12.78--91.47------
FiscalNote Holdings Inc129.63m-27.38m167.37m660.00--1.56--1.29-0.2523-0.25230.96220.7680.337--9.10196,412.10-7.12---8.60--83.96---21.12-----2.030.5771--16.60--53.45------
SoundThinking Inc102.39m-1.89m168.99m312.00--2.2320.361.65-0.1508-0.15088.065.920.7982--3.23328,179.50-1.470.5445-2.561.0358.7257.71-1.850.7096----0.08470.0014.4621.68-142.57---8.35--
Data as of Sep 20 2024. Currency figures normalised to OptimizeRx Corp's reporting currency: US Dollar USD

Institutional shareholders

48.56%Per cent of shares held by top holders
HolderShares% Held
First Light Asset Management LLCas of 30 Jun 20241.83m9.97%
Divisadero Street Capital Management LPas of 30 Jun 20241.32m7.18%
BlackRock Fund Advisorsas of 30 Jun 20241.09m5.92%
AWM Investment Co., Inc.as of 30 Jun 20241.00m5.47%
The Vanguard Group, Inc.as of 30 Jun 2024938.27k5.12%
Samjo Management LLCas of 30 Jun 2024779.51k4.26%
William Blair Investment Management LLCas of 30 Jun 2024643.76k3.51%
Rice, Hall, James & Associates LLCas of 30 Jun 2024496.14k2.71%
Geode Capital Management LLCas of 30 Jun 2024415.93k2.27%
G2 Investment Partners Management LLCas of 30 Jun 2024392.25k2.14%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.